These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 30444134)

  • 41. Altered intestinal microbiota as a major driving force in alcoholic steatohepatitis.
    Tilg H; Mathurin P
    Gut; 2016 May; 65(5):728-9. PubMed ID: 26786686
    [No Abstract]   [Full Text] [Related]  

  • 42. Targeting the gut-liver axis in liver disease.
    Wiest R; Albillos A; Trauner M; Bajaj JS; Jalan R
    J Hepatol; 2017 Nov; 67(5):1084-1103. PubMed ID: 28526488
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Intestinal Microbiome in Nonalcoholic Fatty Liver Disease.
    Puri P; Sanyal AJ
    Clin Liver Dis; 2018 Feb; 22(1):121-132. PubMed ID: 29128052
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The intestinal microbiota in chronic liver disease.
    Henao-Mejia J; Elinav E; Thaiss CA; Flavell RA
    Adv Immunol; 2013; 117():73-97. PubMed ID: 23611286
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intestinal hormones, gut microbiota and non-alcoholic fatty liver disease.
    Koukias N; Buzzetti E; Tsochatzis EA
    Minerva Endocrinol; 2017 Jun; 42(2):184-194. PubMed ID: 27879962
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of intestinal microbiota in the formation of non-alcoholic fatty liver disease.
    Akhmedov VA; Gaus OV
    Ter Arkh; 2019 Mar; 91(2):143-148. PubMed ID: 31094185
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Major depression and liver disease: the role of microbiome and inflammation].
    Kahl KG; Krüger T; Eckermann G; Wedemeyer H
    Fortschr Neurol Psychiatr; 2019 Feb; 87(1):12-21. PubMed ID: 29490382
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intestinal Barrier Function-Non-alcoholic Fatty Liver Disease Interactions and Possible Role of Gut Microbiota.
    Cui Y; Wang Q; Chang R; Zhou X; Xu C
    J Agric Food Chem; 2019 Mar; 67(10):2754-2762. PubMed ID: 30798598
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Gut microbiota and liver disease.
    Goel A; Gupta M; Aggarwal R
    J Gastroenterol Hepatol; 2014 Jun; 29(6):1139-48. PubMed ID: 24547986
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Liver disease of the alcoholic: pathogenesis and metabolic complications.
    Lieber CS
    Ala J Med Sci; 1975 Oct; 12(4):355-60. PubMed ID: 1200320
    [No Abstract]   [Full Text] [Related]  

  • 51. Alcohol, liver disease and the gut microbiota.
    Bajaj JS
    Nat Rev Gastroenterol Hepatol; 2019 Apr; 16(4):235-246. PubMed ID: 30643227
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nonalcoholic Fatty Liver Disease and the Gut Microbiome.
    Boursier J; Diehl AM
    Clin Liver Dis; 2016 May; 20(2):263-75. PubMed ID: 27063268
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Gut microbiota, intestinal permeability, obesity-induced inflammation, and liver injury.
    Frazier TH; DiBaise JK; McClain CJ
    JPEN J Parenter Enteral Nutr; 2011 Sep; 35(5 Suppl):14S-20S. PubMed ID: 21807932
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Human Gut Microbiome in Liver Diseases.
    Davis BC; Bajaj JS
    Semin Liver Dis; 2017 May; 37(2):128-140. PubMed ID: 28564721
    [No Abstract]   [Full Text] [Related]  

  • 55. [Behavior of lipid classes and fatty acids in different stages of alcoholic liver disease].
    Marzo A; Ghirardi P
    Recenti Prog Med; 1971 Nov; 51(5):409-19. PubMed ID: 5172395
    [No Abstract]   [Full Text] [Related]  

  • 56. Fighting Fatty Liver Diseases with Nutritional Interventions, Probiotics, Symbiotics, and Fecal Microbiota Transplantation (FMT).
    Nobili V; Mosca A; Alterio T; Cardile S; Putignani L
    Adv Exp Med Biol; 2019; 1125():85-100. PubMed ID: 30578461
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The relevance of pyroptosis in the pathogenesis of liver diseases.
    Guo H; Xie M; Zhou C; Zheng M
    Life Sci; 2019 Apr; 223():69-73. PubMed ID: 30831126
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Distinctly altered gut microbiota in the progression of liver disease.
    Xie G; Wang X; Liu P; Wei R; Chen W; Rajani C; Hernandez BY; Alegado R; Dong B; Li D; Jia W
    Oncotarget; 2016 Apr; 7(15):19355-66. PubMed ID: 27036035
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The gut microbiota of nonalcoholic fatty liver disease: current methods and their interpretation.
    van Best N; Jansen PL; Rensen SS
    Hepatol Int; 2015 Jul; 9(3):406-15. PubMed ID: 26067771
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Probiotics and Liver Disease: Where Are We Now and Where Are We Going?
    Elzouki AN
    J Clin Gastroenterol; 2016; 50 Suppl 2, Proceedings from the 8th Probiotics, Prebiotics & New Foods for Microbiota and Human Health meeting held in Rome, Italy on September 13-15, 2015():S188-S190. PubMed ID: 27741172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.